Hossain Monshizadegan

Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering

Tracy Mitchell, Ginger Chao, Doree Sitkoff et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 128 citations

Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F₁F₀-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity

Gary J. Grover, Karnail S. Atwal, Paul G. Sleph et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2004 · 115 citations

Cardiac Muscle, Excessive Atp Hydrolysis, Mitochondrial Biology +16

Dual Angiotensin II and Endothelin A Receptor Antagonists:  Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics

Natesan Murugesan, Zhengxiang Gu, Leena Fadnis et al. · Journal of Medicinal Chemistry · 2004 · 86 citations

Cardiovascular Pharmacology, Receptor Antagonist, Pharmacotherapy +16

The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta

Maria L. Webb, Kenneth E.J. Dickinson, Carol L. Delaney et al. · Biochemical and Biophysical Research Communications · 1992 · 56 citations

Hypertension, Cardiovascular Disease, Medicine +11

Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells

Maria L. Webb, Eddie C.‐K. Liu, Robert Cohen et al. · Peptides · 1992 · 55 citations

Molecular Pharmacology, Molecular Characterization, Molecular Physiology +11